Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C-Registry.

Thomas BergUwe NaumannAlbrecht StoehrChristoph SickChristine JohnGerlinde TeuberWillibold SchiffelholzStefan MaussKristina LohmannBettina KönigAndreas PangerlClaus Niederau

Published in: Alimentary pharmacology & therapeutics (2019)

Glecaprevir/pibrentasvir was highly effective and well tolerated under real-world conditions. Clinical trial number: DRKS00009717 (German Clinical Trials Register, DRKS).

Keyphrases

clinical trial
phase ii
open label
study protocol
electronic health record
double blind
phase iii
big data
randomized controlled trial
machine learning
combination therapy
liver fibrosis